Sandoz

Sandoz is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our global portfolio comprises approximately 1 000 molecules, covering all major therapeutic areas, which accounted for 2023 sales of USD 9+ billion. Sandoz is headquartered in Basel, Switzerland. View More